SUPPLY AGREEMENTSupply Agreement • May 3rd, 2012 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 3rd, 2012 Company IndustrySUPPLY AGREEMENT, dated as of November 1, 2010 (the “Agreement”), by and between Ortho-McNeil-Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“Seller”), and Watson Laboratories, Inc., a Nevada corporation (“Purchaser”).
Confidential Portions of this Exhibit marked as [**] have been omitted pursuant to a request for confidentiality and filed separately with the Securities and Exchange Commission.Supply and Distribution Agreement • May 3rd, 2012 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 3rd, 2012 Company Industry JurisdictionWHEREAS, PFIZER and its Affiliates own the following U.S, Patents relating to PFIZER’s drug Lipitor®: 4,681,893 (“893 Patent”), 5,273,995 (“995 Patent”), 5,686,104 (“104 Patent”), 5,969,156 (“156 Patent”) and 6,126,971 (“971 Patent”);